Androgen Therapy for Patients With Lower-Risk Myelodysplastic Syndrome and Significant Cytopenia: A Retrospective Study

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.16121
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

A Retrospective Evaluation of Patients With Myelodysplastic Syndrome

Experimental Biomedical Research
2019English

Long-Term Outcome of Immunosuppressive Therapy for Japanese Patients With Lower-Risk Myelodysplastic Syndromes

International Journal of Hematology
Hematology
2013English

Clinical Efficacy of Chelation Therapy in Patients With Low-Risk Myelodysplastic Syndrome

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2019English

A Nationwide Survey of Hypoplastic Myelodysplastic Syndrome (A Multicenter Retrospective Study)

American Journal of Hematology
Hematology
2017English

Association Between Ischaemic Bowel Syndromes and Androgen Deprivation Therapy in Patients With Prostate Cancer: A Retrospective Cohort Study

BMJ Open
Medicine
2017English

Prognostic Markers of Efficiency of Immunosupressive Therapy in Patients With Myelodysplastic Syndrome

ScienceRise
2015English

Is Neoadjuvant Androgen Deprivation Therapy Necessary for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy?

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Superior Outcome With Hypomethylating Therapy in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome and Chromosome 5 and 7 Abnormalities

Cancer
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy